328 related articles for article (PubMed ID: 24715514)
21. What is adolescent polycystic ovary syndrome?
Peña AS; Metz M
J Paediatr Child Health; 2018 Apr; 54(4):351-355. PubMed ID: 29280221
[TBL] [Abstract][Full Text] [Related]
22. Polycystic ovary syndrome.
Goudas VT; Dumesic DA
Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
[TBL] [Abstract][Full Text] [Related]
23. Polycystic ovary syndrome.
Kahn JA; Gordon CM
Adolesc Med; 1999 Jun; 10(2):321-36. PubMed ID: 10370713
[TBL] [Abstract][Full Text] [Related]
24. Genetic, hormonal and metabolic aspects of PCOS: an update.
De Leo V; Musacchio MC; Cappelli V; Massaro MG; Morgante G; Petraglia F
Reprod Biol Endocrinol; 2016 Jul; 14(1):38. PubMed ID: 27423183
[TBL] [Abstract][Full Text] [Related]
25. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
[TBL] [Abstract][Full Text] [Related]
26. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
27. Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome.
Lentscher JA; Decherney AH
Clin Obstet Gynecol; 2021 Mar; 64(1):3-11. PubMed ID: 32701517
[TBL] [Abstract][Full Text] [Related]
28. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
29. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence.
Merino PM; Codner E; Cassorla F
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):590-8. PubMed ID: 22218441
[TBL] [Abstract][Full Text] [Related]
30. Comparison of PCOS phenotypes in adolescent and young adult Mediterranean women with possible PCOS.
Fruzzetti F; Baldari F; Palla G; Fidecicchi T; Carmina E
J Endocrinol Invest; 2021 May; 44(5):995-1000. PubMed ID: 32839937
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome in adolescence.
Driscoll DA
Ann N Y Acad Sci; 2003 Nov; 997():49-55. PubMed ID: 14644809
[TBL] [Abstract][Full Text] [Related]
32. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
[TBL] [Abstract][Full Text] [Related]
33. Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome.
Sung YA; Oh JY; Chung H; Lee H
Fertil Steril; 2014 Mar; 101(3):840-5. PubMed ID: 24424368
[TBL] [Abstract][Full Text] [Related]
34. A review of polycystic ovarian syndrome in adolescents.
Brewer M; Pawelczak M; Kessler M; Shah B
Minerva Pediatr; 2010 Oct; 62(5):459-73. PubMed ID: 20940680
[TBL] [Abstract][Full Text] [Related]
35. Polycystic Ovary Syndrome: Common Questions and Answers.
Williams T; Moore JB; Regehr J
Am Fam Physician; 2023 Mar; 107(3):264-272. PubMed ID: 36920819
[TBL] [Abstract][Full Text] [Related]
36. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
37. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
38. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report.
Ravi SJ; Cree-Green M
J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263
[TBL] [Abstract][Full Text] [Related]
39. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
[TBL] [Abstract][Full Text] [Related]
40. The Diagnostic Value of Anti-Müllerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome.
Kocaay P; Siklar Z; Buyukfirat S; Berberoglu M
J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):362-366. PubMed ID: 29462707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
